Daniéle Caruelle

585 total citations
17 papers, 496 citations indexed

About

Daniéle Caruelle is a scholar working on Molecular Biology, Cell Biology and Immunology and Allergy. According to data from OpenAlex, Daniéle Caruelle has authored 17 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cell Biology and 5 papers in Immunology and Allergy. Recurrent topics in Daniéle Caruelle's work include Proteoglycans and glycosaminoglycans research (11 papers), Fibroblast Growth Factor Research (7 papers) and Cell Adhesion Molecules Research (5 papers). Daniéle Caruelle is often cited by papers focused on Proteoglycans and glycosaminoglycans research (11 papers), Fibroblast Growth Factor Research (7 papers) and Cell Adhesion Molecules Research (5 papers). Daniéle Caruelle collaborates with scholars based in France and United Kingdom. Daniéle Caruelle's co-authors include Denis Barritault, José Courty, Jean‐Pierre Caruelle, Jean Delbé, Mylène Perderiset, Sandrine Palcy, Isabelle Bernard‐Pierrot, Dominique Chopin, C.C. Abbou and Marc Colombel and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Daniéle Caruelle

17 papers receiving 480 citations

Peers

Daniéle Caruelle
Gavin White United Kingdom
Frederick Kweh United States
Benjamin L. Holley United States
Tracey Amanda Martin United Kingdom
Masahiro Yanagisawa United States
Lynn M. McCormick United States
Jessica B. Casaletto United States
Gavin White United Kingdom
Daniéle Caruelle
Citations per year, relative to Daniéle Caruelle Daniéle Caruelle (= 1×) peers Gavin White

Countries citing papers authored by Daniéle Caruelle

Since Specialization
Citations

This map shows the geographic impact of Daniéle Caruelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniéle Caruelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniéle Caruelle more than expected).

Fields of papers citing papers by Daniéle Caruelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniéle Caruelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniéle Caruelle. The network helps show where Daniéle Caruelle may publish in the future.

Co-authorship network of co-authors of Daniéle Caruelle

This figure shows the co-authorship network connecting the top 25 collaborators of Daniéle Caruelle. A scholar is included among the top collaborators of Daniéle Caruelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniéle Caruelle. Daniéle Caruelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Achour, Ammar, et al.. (2008). Pleiotrophin induces expression of inflammatory cytokines in peripheral blood mononuclear cells. Biochimie. 90(11-12). 1791–1795. 20 indexed citations
2.
Hamma‐Kourbali, Yamina, Isabelle Bernard‐Pierrot, Mélanie Héroult, et al.. (2007). Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C‐thrombospondin repeat‐I domain. Journal of Cellular Physiology. 214(1). 250–259. 28 indexed citations
3.
Debeir, Thomas, Juan E. Ferrario, Jean Delbé, et al.. (2005). Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons: Analysis of suppression-subtracted cDNA libraries and confirmation in vitro. Experimental Neurology. 194(1). 243–254. 24 indexed citations
4.
Caruelle, Daniéle, Jean Delbé, Arlette Duchesnay, et al.. (2004). Upregulation of HARP during in vitro myogenesis and rat soleus muscle regeneration. Journal of Muscle Research and Cell Motility. 25(1). 45–53. 11 indexed citations
5.
Soulié, P, Mélanie Héroult, Isabelle Bernard‐Pierrot, et al.. (2004). Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients. Cancer Detection and Prevention. 28(5). 319–324. 15 indexed citations
6.
Soulié, P, Mélanie Héroult, I Bernard, et al.. (2002). IMMUNOASSAY FOR MEASURING THE HEPARIN-BINDING GROWTH FACTORS HARP AND MK IN BIOLOGICAL FLUIDS. Journal of Immunoassay and Immunochemistry. 23(1). 33–48. 19 indexed citations
7.
Bernard‐Pierrot, Isabelle, Jean Delbé, Marc Vigny, et al.. (2002). Dominant Negative Effectors of Heparin Affin Regulatory Peptide (HARP) Angiogenic and Transforming Activities. Journal of Biological Chemistry. 277(35). 32071–32077. 25 indexed citations
8.
Bernard‐Pierrot, Isabelle, Jean Delbé, Daniéle Caruelle, et al.. (2001). The Lysine-rich C-terminal Tail of Heparin Affin Regulatory Peptide Is Required for Mitogenic and Tumor Formation Activities. Journal of Biological Chemistry. 276(15). 12228–12234. 36 indexed citations
9.
Ledoux, Dominique, Daniéle Caruelle, Jean‐Christophe Sabourin, et al.. (1997). Cellular Distribution of the Angiogenic Factor Heparin Affin Regulatory Peptide (HARP) mRNA and Protein in the Human Mammary Gland. Journal of Histochemistry & Cytochemistry. 45(9). 1239–1245. 18 indexed citations
10.
Vacherot, Francis, et al.. (1995). Biochemical and mitogenic properties of the heparin-binding growth factor HARP. PubMed. 6(1). 25–34. 18 indexed citations
11.
Zhu, Dingliang, et al.. (1994). Involvement of Calcium Channels in Fibroblast Growth Factor-Induced Activation of Arterial Cells in Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 23(3). 395–400. 12 indexed citations
12.
Zhu, Dingliang, et al.. (1994). Involvement of Calcium Channels in Fibroblast Growth Factor-Induced Activation of Arterial Cells in Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 23(3). 395–400. 11 indexed citations
13.
Chopin, Dominique, Jean‐Pierre Caruelle, Marc Colombel, et al.. (1993). Increased Immunodetection of Acidic Fibroblast Growth Factor in Bladder Cancer, Detectable in Urine. The Journal of Urology. 150(4). 1126–1130. 99 indexed citations
14.
Barritault, Denis, et al.. (1991). aFGF Content Increases with Malignancy in Human Chondrosarcoma and Bladder Cancera. Annals of the New York Academy of Sciences. 638(1). 387–393. 9 indexed citations
15.
Courty, José, et al.. (1991). Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochemical and Biophysical Research Communications. 180(1). 145–151. 101 indexed citations
16.
Bladier, Dominique, et al.. (1990). Soluble heparin-binding lectins from human brain: Purification, specificity and relationship to an heparin-binding growth factor. International Journal of Biochemistry. 22(5). 539–544. 11 indexed citations
17.
Caruelle, Daniéle, Jacques Grassi, José Courty, et al.. (1988). Development and testing of radio and enzyme immunoassays for acidic fibroblast growth factor (aFGF). Analytical Biochemistry. 173(2). 328–339. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026